Knockdown of any component of the CRL4BDCAF11 E3 complex leads to decreased ubiquitination levels of p21Cip1, reduced osteosarcoma cell proliferation, and restoration of p21′s inhibitory effect on CDK2, resulting in cell cycle arrest [48]. The gene discussed is CDKN1A; the disease is osteosarcoma.